CVR: 38732730
DKK -3,160,505
Gross profit
Net result: DKK -7,053,665
EXPRES2ION BIOTECHNOLOGIES ApS, NextGen Vaccines Holding ApS
CVR · view ownership and management
Owner registered: EXPRES2ION BIOTECHNOLOGIES ApS
CVR · 01/02/2021
View the full event history
AdaptVac ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Willem Adriaan De Jongh and Adam Frederik Sander Bertelsen. The company is owned by EXPRES2ION BIOTECHNOLOGIES ApS and NextGen Vaccines Holding ApS. In 2025, the company reported a gross profit of DKK -3,160,505 and a net result of DKK -7,053,665 compared with DKK 1,714,349 the year before. Equity in the 2025 report amounted to DKK 10,808,696.
Virksomhedens formål er at udvikle produkter og teknologi indenfor området vacciner og immunterapi samt hermed efter ledelsens skøn beslægtet virksomhed og serviceydelser.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -3.2 mio. | -7.1 mio. | 23 mio. | 10.8 mio. | 7 | |
| 202401/01/2024 – 31/12/2024 | 8.4 mio. | 1.7 mio. | 20 mio. | 17.9 mio. | 6 | |
| 202301/01/2023 – 31/12/2023 | 69.2 mio. | 50.9 mio. | 98.2 mio. | 58.6 mio. | 6 | |
| 202201/01/2022 – 31/12/2022 | -1.6 mio. | -4.8 mio. | 14 mio. | 7.8 mio. | 6 | |
| 202101/01/2021 – 31/12/2021 | 1.3 mio. | -1.8 mio. | 15.2 mio. | 12.6 mio. | 5 | |
| 202001/01/2020 – 31/12/2020 | 20.2 mio. | 15.5 mio. | 38.6 mio. | 15.3 mio. | 3 | |
| 201901/01/2019 – 31/12/2019 | 1.4 mio. | -185 t. | 1.4 mio. | -122 t. | 3 | |
| 201801/01/2018 – 31/12/2018 | 432 t. | 334 t. | 92 t. | 64 t. | 0 |
Compared to 1.041 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorAdaptVac ApS was founded on 22 June 2017.
AdaptVac ApS is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
AdaptVac ApS is owned by EXPRES2ION BIOTECHNOLOGIES ApS and NextGen Vaccines Holding ApS.
adaptvac.com belongs to AdaptVac ApS, CVR number 38732730.
In 2025, AdaptVac ApS reported a gross profit of DKK -3,160,505.
The management of AdaptVac ApS consists of Willem Adriaan De Jongh and Adam Frederik Sander Bertelsen.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new phone: 26394649, new email: [email protected], new website: www.adaptvac.com (June 19, 2026).
AdaptVac ApS has published its annual report for 2025. Gross profit came to DKK -3,160,505, and the net result was DKK -7,053,665.
As of June 10, 2026, Martin Roland Jensen has joined the board of directors of AdaptVac ApS.
As of June 10, 2026, Allan Rosetzsky has left the board of directors of AdaptVac ApS.
AdaptVac ApS has published its annual report for 2024. Gross profit came to DKK 8,392,621, and the net result was DKK 1,714,349.
AdaptVac ApS has published its annual report for 2023. Gross profit came to DKK 69,205,437, and the net result was DKK 50,885,920.
AdaptVac ApS has published its annual report for 2022. Gross profit came to DKK -1,581,922, and the net result was DKK -4,794,662.
AdaptVac ApS has published its annual report for 2021. Gross profit came to DKK 1,330,522, and the net result was DKK -1,781,825.
As of May 5, 2022, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has been appointed auditor of AdaptVac ApS.
AdaptVac ApS has published its annual report for 2020. Gross profit came to DKK 20,231,326, and the net result was DKK 15,460,206.
As of May 27, 2021, Jacob Hjulmand has joined the board of directors of AdaptVac ApS.
As of May 27, 2021, Bent Ulrich Frandsen has left the board of directors of AdaptVac ApS.
As of February 1, 2021, EXPRES2ION BIOTECHNOLOGIES ApS is registered as an owner of AdaptVac ApS with an ownership share of 33%.
AdaptVac ApS has published its annual report for 2019. Gross profit came to DKK 1,417,122, and the net result was DKK -185,145.
As of February 26, 2020, Willem Adriaan De Jongh has left the board of directors of AdaptVac ApS.
As of January 6, 2020, Allan Rosetzsky has joined the board of directors of AdaptVac ApS.
As of January 6, 2020, Morten Agertoug Nielsen has joined the board of directors of AdaptVac ApS.
As of January 6, 2020, Steen Søren Klysner has left the board of directors of AdaptVac ApS.
As of January 5, 2020, Morten Agertoug Nielsen has left the board of directors of AdaptVac ApS.
AdaptVac ApS has published its annual report for 2018. Gross profit came to DKK 431,961, and the net result was DKK 333,539.
AdaptVac ApS has published its interim report for the period June 22, 2017 – December 31, 2017.
As of October 2, 2017, Bent Ulrich Frandsen has joined the board of directors of AdaptVac ApS.
As of October 2, 2017, Willem Adriaan De Jongh has joined the board of directors of AdaptVac ApS.
As of October 2, 2017, Steen Søren Klysner has joined the board of directors of AdaptVac ApS.
As of October 2, 2017, Ali El-Salanti has joined the board of directors of AdaptVac ApS.
As of October 2, 2017, Morten Agertoug Nielsen has joined the board of directors of AdaptVac ApS.
As of October 2, 2017, Adam Frederik Sander Bertelsen has joined the board of directors of AdaptVac ApS.
As of October 2, 2017, Willem Adriaan De Jongh is registered as adm. dir. of AdaptVac ApS.
As of October 1, 2017, Willem Adriaan De Jongh has stepped down as director of AdaptVac ApS.
As of June 22, 2017, Willem Adriaan De Jongh is registered as director of AdaptVac ApS.
As of June 22, 2017, Adam Frederik Sander Bertelsen is registered as director of AdaptVac ApS.
AdaptVac ApS was founded on June 22, 2017.
As of June 21, 2017, NextGen Vaccines Holding ApS is registered as an owner of AdaptVac ApS with an ownership share of 50%.
Companies in the same industry and area
CVR 40766383
CVR 42597333
CVR 46613139
CVR 44504332
CVR 43917897
